drugset / Trial / NCT02809963
Mineralocorticoid Receptor Antagonists in Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to investigate the effect of selective blocking of the mineralocorticoid receptor in patients with type 2 diabetes on insulin resistance, lipid metabolism and myocardial function.
Timeline
- Start
- 2015-11
- Primary completion
- 2017-11
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eplerenone | Unknown | 100 mg | Oral |
| Comparator | Eplerenone | Unknown | 200 mg | Oral |